Skip to content

patrick vermersch

  • MD, PhD
  • 53h-indexImpact measure calculated using publication and citation counts. Updated daily.
  • 12108CitationsNumber of citations received by patrick's publications. Updated daily.

Recent publications

  • Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): A phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

    • Kapoor R
    • Ho P
    • Campbell N
    • et al.
    Get full text
  • Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

    • Kappos L
    • Bar-Or A
    • Cree B
    • et al.
    Get full text

Co-authors (2504)

Other IDs